View ValuationMardia Samyoung Capillary Tubes 将来の成長Future 基準チェック /06現在、 Mardia Samyoung Capillary Tubesの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Metals and Mining 収益成長16.9%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesValuation Update With 7 Day Price Move • Jun 09Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to ₹50.25, the stock trades at a trailing P/E ratio of 15.7x. Average trailing P/E is 21x in the Metals and Mining industry in India. Total returns to shareholders of 397% over the past year.Board Change • Jun 01High number of new and inexperienced directorsThere are 4 new directors who have joined the board in the last 3 years. The company's board is composed of: 4 new directors. No experienced directors. 1 highly experienced director. Chairman Ravindra Mardia is the most experienced director on the board, commencing their role in 1992. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model.New Risk • May 14New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 177% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (177% accrual ratio). Market cap is less than US$10m (₹444.3m market cap, or US$4.64m).お知らせ • May 07Mardia Samyoung Capillary Tubes Company Limited to Report Q4, 2026 Results on May 12, 2026Mardia Samyoung Capillary Tubes Company Limited announced that they will report Q4, 2026 results on May 12, 2026お知らせ • Jan 20Mardia Samyoung Capillary Tubes Company Limited to Report Q3, 2026 Results on Jan 24, 2026Mardia Samyoung Capillary Tubes Company Limited announced that they will report Q3, 2026 results at 12:15 PM, Indian Standard Time on Jan 24, 2026Reported Earnings • Nov 17Second quarter 2026 earnings releasedSecond quarter 2026 results: EPS: ₹0.02. Net income: ₹172.0k (up ₹14.4m from 2Q 2025).New Risk • Nov 17New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 64% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (64% accrual ratio). Revenue is less than US$1m (₹4.1m revenue, or US$46k). Market cap is less than US$10m (₹850.7m market cap, or US$9.60m).お知らせ • Nov 08Mardia Samyoung Capillary Tubes Company Limited to Report Q2, 2026 Results on Nov 11, 2025Mardia Samyoung Capillary Tubes Company Limited announced that they will report Q2, 2026 results on Nov 11, 2025Board Change • Oct 01High number of new and inexperienced directorsThere are 4 new directors who have joined the board in the last 3 years. The company's board is composed of: 4 new directors. No experienced directors. 1 highly experienced director. Chairman Ravindra Mardia is the most experienced director on the board, commencing their role in 1992. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model.お知らせ • Sep 23Mardia Samyoung Capillary Tubes Company Limited Approves Appointment of Ms. Sonal Vaghelaas Independent DirectorMardia Samyoung Capillary Tubes Company Limited approved appointment of Ms. Sonal Vaghela (as Independent Director of the Company.お知らせ • Sep 01Mardia Samyoung Capillary Tubes Company Limited, Annual General Meeting, Sep 21, 2025Mardia Samyoung Capillary Tubes Company Limited, Annual General Meeting, Sep 21, 2025, at 14:00 Indian Standard Time.Board Change • Sep 01High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. No experienced directors. 1 highly experienced director. Chairman Ravindra Mardia is the most experienced director on the board, commencing their role in 1992. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.お知らせ • Aug 05Mardia Samyoung Capillary Tubes Company Limited to Report Q1, 2026 Results on Aug 12, 2025Mardia Samyoung Capillary Tubes Company Limited announced that they will report Q1, 2026 results on Aug 12, 2025Valuation Update With 7 Day Price Move • Jul 08Investor sentiment improves as stock rises 24%After last week's 24% share price gain to ₹24.04, the stock trades at a trailing P/E ratio of 14x. Average trailing P/E is 24x in the Metals and Mining industry in India.Board Change • Jul 08High number of new and inexperienced directorsThere are 4 new directors who have joined the board in the last 3 years. The company's board is composed of: 4 new directors. No experienced directors. 1 highly experienced director. Chairman Ravindra Mardia is the most experienced director on the board, commencing their role in 1992. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model.Valuation Update With 7 Day Price Move • Jun 24Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹12.14, the stock trades at a trailing P/E ratio of 7x. Average trailing P/E is 22x in the Metals and Mining industry in India.Board Change • Jun 02Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. Non-Executive Non-Independent Director Preeti Rawat was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.お知らせ • May 22Mardia Samyoung Capillary Tubes Company Limited to Report Fiscal Year 2025 Results on May 30, 2025Mardia Samyoung Capillary Tubes Company Limited announced that they will report fiscal year 2025 results on May 30, 2025Board Change • Mar 17Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. Non-Executive Non-Independent Director Preeti Rawat was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Board Change • Mar 03Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. Non-Executive Non-Independent Director Preeti Rawat was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.お知らせ • Feb 11Mardia Samyoung Capillary Tubes Company Limited to Report Q3, 2025 Results on Feb 14, 2025Mardia Samyoung Capillary Tubes Company Limited announced that they will report Q3, 2025 results on Feb 14, 2025Board Change • Jan 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. Non-Executive Non-Independent Director Preeti Rawat was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Board Change • Jan 13Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. Non-Executive Non-Independent Director Preeti Rawat was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Board Change • Dec 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. Non-Executive Non-Independent Director Preeti Rawat was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.お知らせ • Oct 15Mardia Samyoung Capillary Tubes Company Limited to Report Q2, 2025 Results on Oct 25, 2024Mardia Samyoung Capillary Tubes Company Limited announced that they will report Q2, 2025 results on Oct 25, 2024Board Change • Sep 09Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. Non-Executive Non-Independent Director Preeti Rawat was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Mardia Samyoung Capillary Tubes は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測BSE:513544 - アナリストの将来予測と過去の財務データ ( )INR Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数3/31/202673922-857-857N/A12/31/202512639N/AN/AN/A9/30/202542600N/A6/30/2025-112N/AN/AN/A3/31/2025N/A12-25-25N/A12/31/20241-20N/AN/AN/A9/30/20241-21N/AN/AN/A6/30/20241-7N/AN/AN/A3/31/2024N/A-5-6-1N/A12/31/20230-2N/AN/AN/A9/30/20230-1N/AN/AN/A6/30/20230-1N/AN/AN/A3/31/2023N/A-200N/A12/31/20220-1N/AN/AN/A9/30/20220-2N/AN/AN/A6/30/20220-1N/AN/AN/A3/31/2022N/A000N/A12/31/2021N/A-2N/AN/AN/A9/30/2021N/A0N/AN/AN/A6/30/2021N/A0N/AN/AN/A3/31/2021N/A000N/A12/31/2020N/A0N/AN/AN/A9/30/2020N/A-1N/AN/AN/A6/30/2020N/A-2N/AN/AN/A3/31/2020N/A-311N/A12/31/2019N/A-3N/AN/AN/A9/30/2019N/A-3N/AN/AN/A6/30/2019N/A-3N/AN/AN/A3/31/2019N/A-3N/A-3N/A12/31/20182-4N/AN/AN/A9/30/2018N/A-4N/AN/AN/A6/30/2018N/A-4N/AN/AN/A3/31/2018N/A-4N/A-3N/A12/31/20173-6N/AN/AN/A9/30/20173-7N/AN/AN/A6/30/2017N/A-4N/AN/AN/A3/31/2017N/A-4N/A-5N/A12/31/201601N/AN/AN/A9/30/201600N/AN/AN/A6/30/20160-3N/AN/AN/A3/31/20160-3N/A-5N/A12/31/20150-6N/AN/AN/A9/30/20150-10N/AN/AN/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: 513544の予測収益成長が 貯蓄率 ( 6.9% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: 513544の収益がIndian市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: 513544の収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: 513544の収益がIndian市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: 513544の収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: 513544の 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YMaterials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/07/10 14:23終値2026/07/10 00:00収益2026/03/31年間収益2026/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Mardia Samyoung Capillary Tubes Company Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Valuation Update With 7 Day Price Move • Jun 09Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to ₹50.25, the stock trades at a trailing P/E ratio of 15.7x. Average trailing P/E is 21x in the Metals and Mining industry in India. Total returns to shareholders of 397% over the past year.
Board Change • Jun 01High number of new and inexperienced directorsThere are 4 new directors who have joined the board in the last 3 years. The company's board is composed of: 4 new directors. No experienced directors. 1 highly experienced director. Chairman Ravindra Mardia is the most experienced director on the board, commencing their role in 1992. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model.
New Risk • May 14New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 177% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (177% accrual ratio). Market cap is less than US$10m (₹444.3m market cap, or US$4.64m).
お知らせ • May 07Mardia Samyoung Capillary Tubes Company Limited to Report Q4, 2026 Results on May 12, 2026Mardia Samyoung Capillary Tubes Company Limited announced that they will report Q4, 2026 results on May 12, 2026
お知らせ • Jan 20Mardia Samyoung Capillary Tubes Company Limited to Report Q3, 2026 Results on Jan 24, 2026Mardia Samyoung Capillary Tubes Company Limited announced that they will report Q3, 2026 results at 12:15 PM, Indian Standard Time on Jan 24, 2026
Reported Earnings • Nov 17Second quarter 2026 earnings releasedSecond quarter 2026 results: EPS: ₹0.02. Net income: ₹172.0k (up ₹14.4m from 2Q 2025).
New Risk • Nov 17New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 64% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (64% accrual ratio). Revenue is less than US$1m (₹4.1m revenue, or US$46k). Market cap is less than US$10m (₹850.7m market cap, or US$9.60m).
お知らせ • Nov 08Mardia Samyoung Capillary Tubes Company Limited to Report Q2, 2026 Results on Nov 11, 2025Mardia Samyoung Capillary Tubes Company Limited announced that they will report Q2, 2026 results on Nov 11, 2025
Board Change • Oct 01High number of new and inexperienced directorsThere are 4 new directors who have joined the board in the last 3 years. The company's board is composed of: 4 new directors. No experienced directors. 1 highly experienced director. Chairman Ravindra Mardia is the most experienced director on the board, commencing their role in 1992. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Sep 23Mardia Samyoung Capillary Tubes Company Limited Approves Appointment of Ms. Sonal Vaghelaas Independent DirectorMardia Samyoung Capillary Tubes Company Limited approved appointment of Ms. Sonal Vaghela (as Independent Director of the Company.
お知らせ • Sep 01Mardia Samyoung Capillary Tubes Company Limited, Annual General Meeting, Sep 21, 2025Mardia Samyoung Capillary Tubes Company Limited, Annual General Meeting, Sep 21, 2025, at 14:00 Indian Standard Time.
Board Change • Sep 01High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. No experienced directors. 1 highly experienced director. Chairman Ravindra Mardia is the most experienced director on the board, commencing their role in 1992. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
お知らせ • Aug 05Mardia Samyoung Capillary Tubes Company Limited to Report Q1, 2026 Results on Aug 12, 2025Mardia Samyoung Capillary Tubes Company Limited announced that they will report Q1, 2026 results on Aug 12, 2025
Valuation Update With 7 Day Price Move • Jul 08Investor sentiment improves as stock rises 24%After last week's 24% share price gain to ₹24.04, the stock trades at a trailing P/E ratio of 14x. Average trailing P/E is 24x in the Metals and Mining industry in India.
Board Change • Jul 08High number of new and inexperienced directorsThere are 4 new directors who have joined the board in the last 3 years. The company's board is composed of: 4 new directors. No experienced directors. 1 highly experienced director. Chairman Ravindra Mardia is the most experienced director on the board, commencing their role in 1992. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model.
Valuation Update With 7 Day Price Move • Jun 24Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹12.14, the stock trades at a trailing P/E ratio of 7x. Average trailing P/E is 22x in the Metals and Mining industry in India.
Board Change • Jun 02Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. Non-Executive Non-Independent Director Preeti Rawat was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
お知らせ • May 22Mardia Samyoung Capillary Tubes Company Limited to Report Fiscal Year 2025 Results on May 30, 2025Mardia Samyoung Capillary Tubes Company Limited announced that they will report fiscal year 2025 results on May 30, 2025
Board Change • Mar 17Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. Non-Executive Non-Independent Director Preeti Rawat was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Board Change • Mar 03Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. Non-Executive Non-Independent Director Preeti Rawat was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Feb 11Mardia Samyoung Capillary Tubes Company Limited to Report Q3, 2025 Results on Feb 14, 2025Mardia Samyoung Capillary Tubes Company Limited announced that they will report Q3, 2025 results on Feb 14, 2025
Board Change • Jan 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. Non-Executive Non-Independent Director Preeti Rawat was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Board Change • Jan 13Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. Non-Executive Non-Independent Director Preeti Rawat was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Board Change • Dec 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. Non-Executive Non-Independent Director Preeti Rawat was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Oct 15Mardia Samyoung Capillary Tubes Company Limited to Report Q2, 2025 Results on Oct 25, 2024Mardia Samyoung Capillary Tubes Company Limited announced that they will report Q2, 2025 results on Oct 25, 2024
Board Change • Sep 09Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. Non-Executive Non-Independent Director Preeti Rawat was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.